山东凯盛新材料股份有限公司关于控股股东权益变动比例触及1%整数倍的公告

Core Viewpoint - The announcement details a change in the equity stake of the controlling shareholder, Huabang Health, due to the conversion of convertible bonds, resulting in a decrease from 28.98% to 27.98%, which triggers a 1% integer change but does not affect control or governance of the company [2][3]. Group 1: Shareholder Equity Change - The equity change is primarily due to the conversion of some convertible bondholders, leading to an increase in total share capital and a passive dilution of Huabang Health's shareholding [2][3]. - The change does not trigger a mandatory takeover bid and will not result in a change of the controlling shareholder or actual controller [2][3]. Group 2: Convertible Bond Redemption - The last conversion date for the "Kaisheng Convertible Bonds" is January 14, 2026, after which unconverted bonds will be redeemed at a price of 100.10 yuan per bond [5][19]. - The redemption process includes a series of important dates: trading will stop on January 12, 2026, and redemption will occur on January 15, 2026 [21][23]. - Investors are advised to convert or sell their bonds before the deadline to avoid forced redemption [5][6]. Group 3: Convertible Bond Issuance and Terms - The company issued 6.5 million convertible bonds at a face value of 100 yuan each, raising a total of 650 million yuan [9][10]. - The initial conversion price was set at 20.26 yuan per share, subject to adjustments based on dividend distributions [11][12]. - The bonds have conditional redemption clauses that allow the company to redeem them if certain stock price conditions are met [16][18].